Health
Diabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study finds
- Type 2 diabetes patients on GLP-1 treatments, such as Ozempic, have a lower risk of 10 obesity-related cancers compared to those on insulin and other drugs, according to a new study.
- GLP-1 treatments for type 2 diabetes have been on the market for nearly 20 years, improving blood sugar control and inducing weight loss.
- Ozempic, approved in 2017, was one of the first in its class.
Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published on Friday.
GLP-1 treatments for type 2 diabetes have been on the market for nearly 20 years. The newer generation – such as Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro – are far more effective at controlling blood sugar levels and inducing weight loss. Ozempic was the first of the newer generation in the class to be approved, in 2017.
In the study published on Friday in medical journal JAMA Network Open, researchers examined the medical records of 1.6 million patients with type 2 diabetes who had no prior history of 13 types of obesity-related cancers including gallbladder cancer and kidney cancer.
OZEMPIC AND WEGOVY COULD DOUBLE AS KIDNEY DISEASE TREATMENT, STUDY SUGGESTS
The study did not specify which GLP-1 medicines the patients took, but the records were for patients on these medicines or insulin or the diabetes drug metformin between March 2005 and November 2018. Ozempic was only approved by the U.S. Food and Drug Administration in December 2017.
The study found that the patients treated with a GLP-1 therapy instead of insulin “had a significant risk reduction” in 10 of those cancers.
The findings are “preliminary evidence of the potential benefit” of GLP-1 drugs for cancer prevention in high-risk population, the researchers concluded. They also said that studies of the newer generation of these medicines for their cancer preventative effects are warranted.
The authors of the study did not report having received funds from drugmakers who market these medicines.
The versions of these medicines that are approved to treat obesity, and have been shown to help patients lose as much as 20% of their weight on average, have exploded in popularity, leading to record profits for Novo and Lilly.
Lilly’s Mounjaro and weight-loss therapy Zepbound, as well as Novo’s rival medicines Ozempic and Wegovy are already being studied to see whether they can improve health in many other ways, ranging from alcohol addiction to sleep apnea.
In March, the U.S. Food and Drug Administration approved Wegovy for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.
Health
Breast cancer spikes among women under 50, plus healthy foods that are high in calories
Fox News’ Health newsletter brings you stories on the latest developments in health care, wellness, diseases, mental health and more.
TOP 3:
– Breast cancer cases spike among women under 50, new report reveals
– Nutritionist warns these 6 “healthy” foods aren’t helpful for weight loss
– Harvard medical student eats 720 eggs in one month and shares the shocking results
ESSENTIAL FOR ALL? – If you take ANY vitamins, which should you take? Here’s what to know. Continue reading…
‘IT’S TOXIC’ – Experts say drinking alcohol is linked to these six types of cancer. Continue reading…
RECIPE FOR REST – Doing this activity before bed could help improve your quality of sleep. Continue reading…
UNFAITHFUL FINDINGS – More than half of Americans with STDs were infected by cheating partners, a survey revealed. Continue reading…
FOLLOW FOX NEWS ON SOCIAL MEDIA
YouTube
SIGN UP FOR OUR NEWSLETTERS
Fox News First
Fox News Opinion
Fox News Lifestyle
Fox News Health
Fox News Autos
Fox News Entertainment (FOX411)
DOWNLOAD OUR APPS
Fox News
Fox Business
Fox Weather
Fox Sports
Tubi
WATCH FOX NEWS ONLINE
Fox News Go
STREAM FOX NATION
Fox Nation
Health
Man paralyzed in diving mishap has medical miracle a year after AI-powered brain implant
A New York man who was left paralyzed after a diving accident is starting to regain movement a year after receiving an artificial intelligence-powered implant in his brain.
A year ago, Keith Thomas, 46, was only able to move his arms an inch. Today, after the groundbreaking procedure, he is able to extend his arm, grasp a cup and take a drink using only his thoughts and stimulation.
He has also regained more sensation in his wrist and arm, allowing him to feel the fur of his family’s dog.
JOHNNY DEPP VISITS CHILDREN’S HOSPITAL DRESSED AS CAPTAIN JACK SPARROW IN ‘MAGICAL MOMENT’
In 2020, Thomas was living on Long Island and working as a trader on Wall Street when he experienced a diving accident that left him paralyzed from the chest down.
“I dove into a swimming pool at a friend’s house between the shallow and deep end,” he told Fox News Digital. “I hit the bottom and broke my neck. I blacked out, and I couldn’t move.”
Thomas recalls getting loaded into a helicopter that took him to the hospital for the start of his long recovery.
“It was during COVID, so it was extremely difficult and isolating.”
A ‘groundbreaking’ procedure
Health
Bird flu kills 47 tigers, 3 lions and a panther in Vietnam zoos, state media reports
Forty-seven tigers, three lions and a panther have died in zoos in south Vietnam due to the bird flu, state media said.
According to the Vietnam News Agency (VNA), the mammals died at the private My Quynh safari park in Long An province and the Vuon Xoai zoo in Dong Nai, near Ho Chi Minh City.
According to test results from the National Centre for Animal Health Diagnosis, the animals died “because of H5N1 type A virus,” VNA said.
The report noted that no zoo staff members were in close contact with the animals that contracted the disease.
FIRST CASE OF HUMAN BIRD FLU DIAGNOSED WITHOUT EXPOSURE TO INFECTED ANIMALS, CDC SAYS
The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have said that there has been an increase in outbreaks among mammals caused by influenza viruses, including avian influenza A (H5).
In the U.S., a patient in Missouri was diagnosed with bird flu in September.
The patient, who had underlying medical conditions, was successfully treated with antiviral medications at the hospital and has since been discharged, according to the Missouri Department of Health and Senior Services (DHSS).
This marks the 14th person (in three states) to contract bird flu in the U.S. this year — and the first infection to occur without any reported exposure to sick or infected animals, the CDC alert stated.
The prior 13 cases came after exposure to dairy cows or poultry.
Fox News’ Melissa Rudy contributed to this report.
-
Technology2 days ago
Charter will offer Peacock for free with some cable subscriptions next year
-
World1 day ago
Ukrainian stronghold Vuhledar falls to Russian offensive after two years of bombardment
-
News1 week ago
Video: Where Trump and Harris Stand on Democracy
-
World2 days ago
WikiLeaks’ Julian Assange says he pleaded ‘guilty to journalism’ in order to be freed
-
Technology21 hours ago
Beware of fraudsters posing as government officials trying to steal your cash
-
Business1 week ago
Visa, Google, JetBlue: A Guide to a New Era of Antitrust Action
-
Education1 week ago
Video: Los Angeles Bus Hijacked at Gunpoint
-
Politics1 week ago
FLASHBACK: VP Harris pushed for illegal immigrant to practice law in California over Obama admin's objections